Find clinical trials for medical research studies worldwide.
A Study to Test a New Combination Treatment for Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
View Study Details →A Study to Test a New Combination Treatment for Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Disease
View Study Details →A Study to Test a New Combination Treatment for Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Diabetes Mellitus, Type 2, Hypertension, Cardivascular Diseases
View Study Details →A Study to Test a New Combination Treatment for Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
View Study Details →A study to test wearable stimulation therapy for Overactive Bladder
Status: Recruiting — Phase: Pivotal — Start:
Conditions: Healthy Volunteer
View Study Details →Study examining how a high-fibre supplement affects nerve signals that control blood pressure in people with untreated high blood pressure
Status: Recruiting — Phase: Not Applicable — Start:
Conditions: Hypertension
View Study Details →A Study to Test a New Combination Treatment for Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
View Study Details →A Study to Evaluate the Safety and Effectiveness of a New Drug Called Osivelotor in People with Sickle Cell Disease
Status: Recruiting — Phase: Phase 2,Phase 3 — Start:
Conditions: Sickle Cell Disease
View Study Details →A study comparing elismetrep (K-304) to placebo for treating migraine attacks
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Migraine
View Study Details →A study testing whether MTX-474, a new investigational medicine given by IV infusion, is safe and effective for treating diffuse cutaneous systemic sclerosis (a form of scleroderma)
Status: Recruiting — Phase: Phase 2 — Start:
Conditions: Diffuse Cutaneous Systemic Sclerosis
View Study Details →A study of how safe and effective a C. Diff vaccine can be in decreasing infections.
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Clostridoides Difficile Associated Disease
View Study Details →A study testing whether SAB-142 (study medication) can slow down the progression of newly diagnosed Type 1 diabetes
Status: Recruiting — Phase: Phase 2 — Start:
Conditions: Type 1 Diabetes
View Study Details →A study testing whether zilebesiran can reduce heart attacks, strokes, and other cardiovascular problems in people with high blood pressure
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: High Risk Cardiovascular Disease, Hypertension, High Cardiovascular Risk
View Study Details →A research study testing different doses of an investigational medication called brivekimig for people with moderate to severe hidradenitis suppurativa
Status: Recruiting — Phase: Phase 2 — Start:
Conditions: Hidradenitis Suppurativa
View Study Details →SYNERGY-Outcomes: A study testing two medications to prevent serious liver complications in people with metabolic fatty liver disease
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease
View Study Details →A Study of an Investigational Drug (AZD0780) for Reducing the Risk of Major Cardiovascular Events in Patients with Cardiovascular Disease or at High Risk
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Cardiovascular Disease
View Study Details →A first-in-human study testing a new intravenous medication called CPTX2309 to evaluate its safety in healthy volunteers and in people living with moderate to severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Healthy Volunteers, Rheumatoid Arthritis, Systemic Lupus Erythematosus
View Study Details →Testing the safety and dosage range of a natural health product called HP-211 (Axulin) to see if it helps control blood sugar levels in people with Type 2 Diabetes.
Status: Recruiting — Phase: Phase 2 — Start:
View Study Details →A study comparing CDR132L with placebo on heart structure and function in people with heart failure
Status: Recruiting — Phase: Phase 2 — Start:
Conditions: Heart Failure
View Study Details →A study comparing different doses of the new medicine NNC0519-0130 for reducing kidney damage in people with chronic kidney disease
Status: Recruiting — Phase: Phase 2 — Start:
Conditions: Chronic Kidney Disease
View Study Details →